AI Strategy & Roadmap in Gaithersburg, MD

Gaithersburg sits on a strange seam. NIST headquarters runs the national measurement and AI-standards conversation a few miles from here, the Lockheed Martin and IBM Federal campuses anchor a defense-and-government-IT corridor down I-270, and the life-sciences cluster around the old MedImmune campus pushes biotech work in the opposite direction. Most operators we talk to in this market sit adjacent to one of those three poles, not inside them. They are the mid-size contractor on a NIST or NIH subcontract, the clinical-stage biotech with forty people and a single Phase 2 program, the regional services firm that bills federal-adjacent work and does not want to learn ai strategy consulting from a Bay Area deck.

The AI conversation here is shaped by that. Owners are not asking whether AI matters — they have already been pitched a dozen tools by a dozen vendors, half of them claiming "NIST AI RMF alignment" without saying what that actually means in their product. What they actually need is an ai consultant who has read the compliance posture before walking in the room. They are trying to figure out which two or three capabilities are worth a real budget, which ones their compliance posture rules out for now, and which ones they should buy off the shelf instead of building. The mistake we see most often in Gaithersburg is the opposite of the one in younger markets: operators here over-index on "we cannot use AI because of compliance," when in reality the lower-risk internal-ops use cases would clear a controls review without much friction.

The other Gaithersburg-specific factor is the build-vs-buy bias. A lot of the operators on this corridor came out of larger federal contractors and they default to "build it ourselves" because that was the cultural answer where they trained. For a thirty-person services firm or a clinical-stage biotech, that is usually the wrong answer for the first capability — there are credible vendors with FedRAMP or HITRUST posture already in production. Good ai consulting surfaces those vendors before anyone signs a build SOW, so the roadmap reflects what is actually available, not just what the team already knows how to build.

Most Gaithersburg engagements start with the $99 AI readiness audit because the owner has already sat through too many vendor pitches and wants a vendor-neutral baseline before spending real money. The audit pulls a real picture of where the operation actually stands: which workflows are repeatable enough for automation, which data sits in systems with usable APIs versus locked behind legacy federal-contractor stacks, where compliance posture genuinely blocks an AI use case versus where it is being used as a polite "no" to an internal request. That report is the artifact the owner takes into the next executive meeting, and it usually reframes the conversation away from tool selection and toward operational reality.

From the audit, two paths. If the owner is not sure which workflow to attack first, we run a $497 Founder Review Call — ninety minutes with the founder, no junior consultants, a written prioritization memo at the end that ranks three to five candidates by effort, revenue impact, and ethical risk. If the audit surfaces a clear leverage point — say a NIST-adjacent contractor where proposal generation is eating partner hours, or a clinical-stage biotech where regulatory document indexing is bottlenecking the medical-affairs team — we scope the strategy engagement directly. Two-day workshop on site at your office or two-week deep dive across multiple stakeholder interviews, depending on team size and how distributed the operation is.

The deliverable is the same either way: a ranked roadmap of three to five capabilities, a build-vs-buy breakdown for the top three, and a Phase 1 scope brief written so any builder — Golden Horizons, an internal team, a federal contractor on your existing GSA schedule — can execute against it. We do not push toward our own implementation pipeline, and the brief is written to be portable. A handful of clients hand the brief to a different builder and we never hear from them again, which is fine. The strategy deliverable is the product. What you do with it is your call.